In early October 2025, Ben Whitehead, a 49-year-old resident of Mount Gambier, South Australia, experienced a dramatic shift in his health. “In a matter of weeks, I went from someone that could run 130 kilometres a week down to someone that struggled to mow a lawn,” he recounted. This abrupt change marked the beginning of his journey with a rare form of cancer, a battle he has shared publicly to inspire others.
Ben’s diagnosis of stage 4 peripheral T-cell lymphoma, a rare and aggressive cancer, has taken him across state lines in search of treatment. Despite the grim prognosis, Ben has maintained a positive outlook, documenting his experiences on social media to raise awareness and support.
A Fateful Hospital Visit
Ben’s ordeal began with an ambulance ride to the local hospital in Mount Gambier, where initial tests revealed the presence of cancer. He was advised to seek further evaluation at Flinders Medical Centre in Adelaide, a journey of nearly five hours by car. “It was going to take at least three weeks to actually see a specialist and that didn’t mean I was going to be treated,” Ben explained.
Encouraged by a family member, Ben made his way to the Peter MacCallum Cancer Centre in Melbourne. There, he received the devastating news of his rare lymphoma. “In an awful situation, I was very lucky to go down the path that I did to get where I was,” he said. His cancer was described by doctors as unprecedented, likening it to “if my T-cell lymphoma caught T-cell lymphoma.”
“Their way of explaining it to me was [it was as] if my T-cell lymphoma caught T-cell lymphoma, that’s how rare it is,” Ben said.
Starting an ‘Unknown Chapter’
After two unsuccessful chemotherapy treatments, Ben’s prognosis remained bleak. In a decisive move, he joined a phase one clinical trial, becoming the first participant worldwide. “They were left with no other choice … the weird bit is, I’m number one in the world on this trial,” he shared. Despite the risks, Ben embraced the opportunity to contribute to medical research.
Dr. Philip Thompson, Ben’s clinician in Melbourne, praised his courage. “It does take a lot of courage to commit to going on a clinical trial,” Dr. Thompson said. “You have to be willing to take a step into the unknown and place your trust in the people who are advising you.”
Unfortunately, a recent PET scan revealed new nodules, leading to Ben’s removal from the trial. “It’s showing that this gremlin is just adapting with everything we’re throwing at it,” he lamented. Despite this setback, Ben remains hopeful for future trials.
Keeping Positive in Dark Times
Ben has turned to social media to share his journey, providing updates and maintaining a connection with friends and family. “I would spend eight or nine hours on the phone each day just keeping people updated,” he said. His openness offers a window into the realities of living with cancer, a perspective often hidden from view.
Beyond his updates, Ben finds solace in humor, often engaging in practical jokes with hospital staff. “I’ve gone in for the check-up and the nurse has come over and gone, ‘How have you gone?'” he recalled. “As I’ve stood up, I’ve flicked out a mouse tail that I’ve made out of a pool noodle and some fur and she’s cracked up laughing.”
“If you think you’ve got something, there’s a good chance it could be, because our bodies know what’s going on,” Ben advised. “We’ve just got to listen to them.”
Ben’s story is a testament to resilience and the human spirit’s capacity to find light in the darkest of times. As he awaits the next steps in his treatment, his journey continues to inspire those around him, reminding us all of the importance of hope and humor in the face of adversity.
